FDA Approves Merck's BRAVECTO QUANTUM Annual Flea And Tick Shot For Dogs

FDA approves shot that protects dogs from fleas and ticks for 8-12 months

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

Blockbuster long acting flea and tick treatment for dogs coming after FDA approval

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).The approval of the new injectable treatment, called Bravecto Quantum, was announced by the federal agency on Thursday.It is the "first FDA-approved drug that protects dogs against fleas and ticks for 8 to 12 months," according to the FDA. Bravecto Quantum can be used for treating and pre…

FDA Approves Merck's BRAVECTO QUANTUM Annual Flea And Tick Shot For Dogs

FDA approves long-acting flea and tick treatment for dogs, marking veterinary breakthrough

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough

STOCK PHOTO/Getty Images (WASHINGTON) — Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The treatment is approved for dogs and puppies 6 months and ol…

First long-acting flea and tick treatment is FDA-approved for dogs

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in dogs.